Download PDF
J Am Acad Audiol 1999; 10(09): 484-488
DOI: 10.1055/s-0042-1748537
Case Report

Auditory Neuropathy and a Mitochondrial Disorder in a Child: Case Study

Virginia M. Corley
Department of Speech-Language Pathology and Audiology, University of South Carolina, Columbia, South Carolina
,
Linda S. Crabbe
Developmental Pediatrics, Tuomey Healthcare Systems, Sumter, South Carolina
› Author Affiliations
› Further Information
  PDF Download  Permissions and Reprints

Abstract

A child was referred for an audiologic evaluation, to include auditory brainstem evoked response testing, due to inconsistent responses to sound and delayed speech and language development. Results were characteristic of auditory neuropathy. In view of subsequent decline in motor function, a genetics evaluation was conducted, revealing a mitochondrial disorder. A brief overview of mitochondrial genetics in association with hearing loss is presented. The patient's audiologic profile is described and the implications for management are discussed.

Abbreviations: ABR = auditory brainstem evoked response, ATP = adenosine triphosphate, DPOAE = distortion-product otoacoustic emissions, MRI = magnetic resonance imaging, mtDNA = mitochondrial deoxyribonucleic acid, nDNA = nuclear deoxyribonucleic acid, OAE = otoacoustic emissions, OXPHOR = oxidative phosphorylation

Key Words

Auditory neuropathy - maternal inheritance - mitochondrial disorder - oxidative phosphorylation


Publication History

Article published online:
05 May 2022

© 1999. American Academy of Audiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • REFERENCES

  • Berlin CI, Hood LJ, Cecola P, Jackson DF, Szabo P. (1993). Does Type I afferent neuron dysfunction reveal itself through lack of efferent suppression? Hear Res 65: 40–50.
  • Berlin CI, Hood LJ, Hurley A, Wen H. (1994). Contralateral suppression of otoacoustic emissions: an index of the function of the medial olivocochlear system: The First Jerger Lecture. Am Acad Otolaryngol Head Neck Surg Found 110(1): 3–21.
  • Bu X, Shohat M, Jaber L, Rotter JI. (1993). A form of sensorineural deafness is determined by a mitochondrial and an autosomal locus: evidence from pedigree segregation analysis. Genet Epidemiol 10: 3–15.
  • Deltenre P, Mansbach AL, Bozet C, Clercx A, Hecox KE. (1997). Auditory neuropathy: a report on three cases with early onsets and major neonatal illnesses. Electro-encephalogr Clin Neurophysiol 104: 17—22.
  • Fischel-Ghodsian N, Prezant TR, Bu X, Oztas S. (1993). Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol 14: 399–403.
  • Gold M, Rapin I. (1994). Non-Mendelian mitochondrial inheritance as a cause of progressive genetic sensorineural hearing loss. Int J Pediatr Otorhinolaryngol 30: 91–104.
  • Harrison RV. (1998). An animal model of auditory neuropathy. Ear Hear 19: 355–361.
  • Matthijs G, Claes S, Longo-Mbenza B, Cassiman J. (1996). Non-syndromic deafness associated with a mutation and a polymorphism in the mitochondrial 12S ribosomal RNA gene in a large Zairean pedigree. Eur J Hum Genet 4: 46–51.
  • Reardon W, Harding AE. (1995). Mitochondrial genetics and deafness. J Audiol Med 4: 40–51.
  • Shoffher JM, Wallace DC. (1995) Oxidative phosphorylation diseases. In: The Metabolic Basis of Inherited Disease. 7th ed., Vol. 1. McGraw-Hill, 1535–1609.
  • Sininger YS, Hood LJ, Starr A, Berlin CI, Picton TW. (1995). Hearing loss due to auditory neuropathy. Audiology Today 7(2): 10–13.
  • Starr A, Picton TW, Sininger YS, Hood LJ, Berlin CI. (1996). Auditory neuropathy. Brain 119: 741–753.
  • Vernham GA, Reid FM, Rundle PA, Jacobs HT. (1994). Bilateral sensorineural hearing loss in members of a maternal lineage with a mitochondrial point mutation. Clin Otolaryngol 19: 314–319.
  • Wallace DC. (1992). Diseases of the mitochondrial DNA. Annu Rev Biochem 61: 1175–1212.
  • Wallace DC. (1993). Mitochondrial diseases: genotype versus phenotype. Trends Genet 9: 128–133.